Financial Services for
Canada's Cannabis Retailers, Cultivators, Processors & Brands.
A senior CPA-backed team delivering bookkeeping, business plans, Fractional CFO and financial modeling built for the way Canadian cannabis actually operates — Health Canada Licence Holder framework for cultivators and processors, AGCO Ontario retail licensing, OCS provincial wholesale, biological asset accounting under IAS 41 for public Licensed Producers, ASPE for private LPs, cannabis excise duty and provincial stamp reconciliation, inventory valuation across harvest and post-harvest stages, cost of cultivation absorption, impairment testing under IAS 36 after industry-wide writedowns, cannabis retail POS integration (Cova, Greenline, Dutchie POS, Meadow, Flowhub), cultivation and seed-to-sale software (Trym, Growlink, Cropify, FloraTrak, Distru), Health Canada CTLS monthly reporting, cannabis-specific banking navigation, and CCAA and turnaround support. Section 280E does not apply in Canada — a meaningful competitive advantage for Canadian operators over US multi-state operators. Serving cannabis retail dispensaries, multi-store operators, micro-cultivators, standard cultivators, craft processors, standard processors, extraction, edibles and beverage manufacturers, testing labs, nurseries, cannabis brands, medical cannabis clinics and ancillary businesses across Toronto, Mississauga, Vaughan, Markham, Brampton, Leamington, Windsor and the broader Ontario cannabis market.
Built for IAS 41, Excise, AGCO & Health Canada.
Cannabis finance in Canada isn't consumer-goods accounting with regulatory paperwork on top. It's a distinct discipline anchored in biological asset accounting under IAS 41, excise duty and stamp reconciliation, Health Canada CTLS reporting, AGCO retail compliance, impairment testing after industry-wide writedowns, and cannabis-specific banking navigation. Generic accountants and even most cannabis-generalist firms routinely fumble every one of these.
CPA-supervised, cannabis-fluent
Every cannabis engagement is led by a senior CPA who's already worked with cannabis retailers, cultivators, processors, edibles and beverage manufacturers, testing labs, brands and ancillary businesses at your stage. No junior handoffs. No offshore delegation. IAS 41 and Health Canada discipline treated as inseparable from day one.
IAS 41 biological assets & IAS 36 impairment
Biological asset fair-value model discipline (grow-cycle assumptions, price assumptions, cost-to-sell adjustments). Harvest-to-inventory transfer at fair value less costs to sell. Post-harvest cost absorption. IAS 36 impairment testing (indicators, cash-generating unit identification, recoverable amount calculation) — a mandatory annual discipline given industry-wide writedowns. Coordination with auditor valuation specialists.
Excise duty, stamp reconciliation & HST
Cannabis excise duty accrual and payment discipline under the federal excise framework with province-specific coordinated rates. Provincial excise stamps as controlled inventory (physically tracked, reconciled to product output). CRA excise reporting cadence. Different product categories (flower, oil, edibles, extracts, topicals, cannabis 2.0) face different excise rules. HST on cannabis with all standard input tax credit discipline.
Health Canada CTLS & AGCO retail
Federal Licence Holders file monthly reports through the Cannabis Tracking and Licensing System (CTLS) covering inventory movements, sales and production activity. Ontario retailers face AGCO reporting obligations including OCS wholesale reconciliation. Accounting records must tie cleanly to what gets filed with the regulator — inconsistencies are a red flag. We provide the financial data and coordination alongside your regulatory affairs team.
Cannabis banking & CCAA turnaround
Cannabis banking in Canada is meaningfully constrained. We help clients navigate the cannabis-banking landscape (which banks serve cannabis, what documentation they require) and handle the specific bookkeeping considerations that come with limited banking. CCAA proceedings, DIP financing coordination, monitor reporting support, sale-of-business processes, and cash-flow-based turnaround planning — extensive experience across sector matters.
Fixed fees, all four services under one roof
Fixed monthly retainer for CFO and bookkeeping. Fixed project fee for business plans and models. Bookkeeping, CFO, business plan and financial modeling from the same team, using the same numbers, telling the same story to your bank, your auditor, Health Canada, AGCO, your investors and any acquirer, buyer or monitor if you're in restructuring or M&A.
What Canadian Cannabis Operators Actually Face.
Canada legalized adult-use cannabis under the federal Cannabis Act in October 2018 — becoming one of the first G7 nations with a fully federally-regulated legal cannabis market. The Canadian cannabis sector spans Health Canada-licensed cultivators (standard cultivators, micro-cultivators, nurseries), processors (standard processors, micro-processors, extraction facilities), sale for medical purposes licence holders, testing labs (Health Canada-licensed analytical labs), AGCO-licensed Ontario retail dispensaries (subject to the 75-store cap per operator in Ontario), multi-store retail operators, asset-light cannabis brands and licensors, cannabis 2.0 product manufacturers (edibles, beverages, topicals, vapes, concentrates), medical cannabis clinics, cannabis technology and software companies, and ancillary businesses (equipment, packaging, consulting, security, banking, professional services).
Cannabis operators face finance realities that don't exist in most sectors. Biological asset accounting under IAS 41 is the single most technically complex accounting discipline in Canadian cannabis. Cannabis plants in cultivation are biological assets measured at fair value less costs to sell, with changes flowing through profit and loss. At harvest, biological assets transfer to inventory at fair value less costs to sell (which becomes deemed cost for inventory purposes). Inventory then absorbs post-harvest costs across drying, curing, testing, packaging and labeling. Getting the fair value model right — grow-cycle assumptions, price assumptions, cost-to-sell adjustments — is the single largest audit and impairment issue every public LP faces. IFRS-compliant policy documentation, model support, and coordination with the auditor's valuation specialists all matter.
Public vs private accounting framework matters materially. Public cannabis Licensed Producers on TSX, TSX-V, CSE or NASDAQ report under IFRS with the biological asset framework above. Private LPs typically report under ASPE (Accounting Standards for Private Enterprises), which permits cost-based inventory measurement and avoids the biological asset volatility that has hurt public LP earnings so significantly. The ASPE-to-IFRS conversion for a private LP preparing for public listing is a distinct project that requires proper planning. Cross-listed operators face both Canadian and US reporting complexity.
A critical point most cross-border operators need to hear early: Section 280E does not apply in Canada. Section 280E is a US Internal Revenue Code provision that denies most business expense deductions to US cannabis operators because cannabis remains federally illegal in the US. Because cannabis is federally legal in Canada under the Cannabis Act, Canadian LPs and retailers can deduct normal operating expenses in the ordinary course. This is a meaningful competitive advantage for Canadian operators over US multi-state operators and is one of the reasons cross-border capital continues to flow into the Canadian sector despite the industry's well-documented profitability struggles.
Cannabis excise duty is imposed under the federal excise framework with province-specific coordinated rates and physical provincial excise stamps. Different product categories (flower, cannabis oil, edibles, extracts, topicals, cannabis 2.0 products) face different excise rules. Excise duty accrual and payment discipline, provincial stamp reconciliation and inventory tracking (stamps are controlled inventory), CRA excise reporting cadence — excise is one of the largest single expense categories for cultivators and processors and the compliance surface is substantial.
Inventory valuation and cost of cultivation absorption is meaningfully more complex than standard product manufacturing. Cultivation-stage costs (labor, utilities, security, depreciation of cultivation equipment, growing supplies) must be absorbed into biological asset carrying value and then into inventory at harvest. Post-harvest stages (drying, curing, testing, packaging, labeling, excise stamp application) each add absorbed cost. Proper cost accumulation across cultivation and post-harvest stages, standard costing where appropriate, and variance analysis all matter. Coordination between cultivation software (Trym, Growlink, Cropify, FloraTrak, Distru), the ERP and the GL is essential.
Impairment testing under IAS 36 is a mandatory annual discipline for public LPs. The Canadian cannabis sector has experienced substantial and repeated impairment writedowns across nearly every major public LP since 2019 — inventory writedowns, goodwill impairment, intangible asset impairment, and PP&E writedowns as capacity utilization has fallen short of forecast. Impairment testing (indicators, cash-generating unit identification, recoverable amount calculation, sensitivity analysis) is non-negotiable, and the disclosure work that follows a material impairment is substantial. On the retail side, cannabis POS integration (Cova dominant in Canadian cannabis retail, Greenline, Dutchie POS, Meadow, Flowhub) with daily sales sync, product-level margin tracking, excise stamp inventory tracking, and AGCO regulatory reporting derived from POS data is a constant rhythm.
Layered on all of that: cannabis banking in Canada is meaningfully more constrained than banking for most industries — many Big Five banks decline direct cannabis relationships, several Schedule I and II banks specialize in cannabis banking, payment processing options are limited. CCAA (Companies' Creditors Arrangement Act) proceedings have been unusually common as many LPs and retailers have restructured, sold assets or wound down. Turnaround finance in cannabis is a specialized field. What cannabis operators need is senior finance leadership at Fractional pricing, deep expertise across IAS 41 biological asset accounting, IAS 36 impairment testing, excise duty and stamp reconciliation, Health Canada CTLS reporting, AGCO retail compliance, cannabis-specific banking navigation, and CCAA and turnaround support. Ledgerive was built for exactly that.
Signs Your Cannabis Operation Needs Ledgerive.
The two service lines cannabis operators reach for first are Bookkeeping (get biological assets, excise, POS integration, CTLS reporting and cannabis banking right) and Business Plans (close cannabis-lender packages, private capital raises, sell-side M&A, buy-side diligence or DIP financing). Here's how to tell when each is the right answer.
You Need Cannabis Bookkeeping When…
Biological asset accounting doesn't exist or is materially wrong, excise duty and stamp reconciliation is inconsistent, Health Canada CTLS reporting doesn't tie to the GL, or your cannabis retail POS data doesn't flow properly. Cannabis accounting is a specialized discipline — and generic accountants (and even most cannabis-generalist firms) routinely miss IAS 41, excise, CTLS alignment and cannabis banking discipline.
- Your public LP biological asset model isn't defensible or your ASPE private LP inventory costing hasn't been properly reviewed
- Excise duty and provincial stamp reconciliation is inconsistent and you're worried about a CRA excise audit
- Health Canada CTLS monthly reporting doesn't tie cleanly to your GL, or AGCO retail reporting is a manual scramble
- Your cannabis retail POS (Cova, Greenline, Dutchie POS, Meadow, Flowhub) captures everything but nothing flows properly to QuickBooks or Xero
You Need a Cannabis Business Plan When…
You have a real deadline — a cannabis-specialty lender package, private capital raise, sell-side M&A close, buy-side diligence, DIP financing decision, impairment cycle, or annual audit — and the plan has to be strong enough to actually close with sophisticated cannabis-familiar reviewers.
- You're preparing a cannabis-specialty lender package or private capital raise for cultivation expansion, retail buildout, or working capital
- You're selling your LP, retail operator or brand and need sell-side EBITDA normalization, add-backs, buyer-ready financials, and a proper CIM
- You're acquiring another cannabis operator and need proper buy-side diligence support and QofE coordination
- You're in or approaching restructuring and need DIP financing modeling, monitor reporting support, or a proper turnaround plan
Cannabis-Native Bookkeeping & Business Plans.
The two services cannabis operators lean on first, delivered end-to-end by a senior CPA-led team with deep Licensed Producer, AGCO retail, cannabis 2.0 manufacturer, testing lab, brand and turnaround specialization. Fractional CFO and Financial Modeling are available alongside as your stage requires.
Bookkeeping for Cannabis
Monthly bookkeeping, weekly cash and inventory snapshots, catch-up bookkeeping, HST and excise filings, and payroll for cannabis operators — tuned to biological asset accounting under IAS 41 for public LPs, ASPE inventory costing for private LPs, cannabis excise duty and provincial stamp reconciliation, Health Canada CTLS monthly reporting, AGCO retail compliance, cannabis retail POS integration (Cova, Greenline, Dutchie POS, Meadow, Flowhub), cultivation software integration (Trym, Growlink, Cropify), and cannabis-specific banking navigation. Reviewed by a CPA.
- IAS 41 biological asset & ASPE inventory discipline
- Excise duty & provincial stamp reconciliation
- Health Canada CTLS & AGCO reporting alignment
- Cannabis POS & cultivation software integration
- IAS 36 impairment testing & cannabis banking navigation
Business Plans for Cannabis
Cannabis-lender-ready, capital-raise-ready, buyer-ready and monitor-ready business plans for cannabis operators — cannabis-specialty lender packages, private capital raise CIMs, sell-side M&A packages with EBITDA normalization and add-back documentation, buy-side diligence support, CCAA and DIP financing packages, monitor reporting support, and turnaround plans. Written for exactly what each reviewer wants to see — cannabis-familiar reviewers demand cannabis-specific fluency.
- Cannabis-specialty lender & capital raise packages
- Sell-side M&A packages & EBITDA normalization
- Buy-side diligence & QofE coordination
- CCAA, DIP financing & monitor reporting packages
- Cannabis 2.0 launch & new-facility economics
Also available for cannabis:
Cannabis Sub-Verticals & Regions We Cover.
Deep specialization across the cannabis sub-verticals that actually define Canada's federally-legal sector — and coverage across every core Ontario cannabis region plus remote engagement across Canada.
Cannabis sub-verticals we serve
Our deepest expertise — across the full spectrum from Health Canada Licensed Producers to AGCO retail to cannabis 2.0 manufacturers to brands and ancillary.
Ontario cannabis regions we cover
Remote-first for everyone, including operators outside Ontario. On-site quarterly reviews available across every Ontario city below.
Remote-First, CTLS & AGCO Report-Aligned.
The engagement rhythm every cannabis operator can expect — designed around your daily POS or cultivation cadence, weekly cash flow, monthly CTLS or AGCO reporting, and audit or restructuring calendar.
Free 30-min discovery call
NDA before the call, always. We walk through your licence type, your operations, your accounting framework (IFRS or ASPE), your priorities and deadlines. Honest answer on fit inside the call itself — not a follow-up email.
Written proposal in 48 hours
Scope, deliverables, timeline and fixed fee — all in writing. If the scope needs to change, we redraft once for free. What we quote is what you pay.
Start in 3–5 business days
Engagement letter signed. Access granted to your POS or cultivation software, ERP or QuickBooks/Xero, Health Canada CTLS portal where applicable, AGCO portal for retail, bank feeds and prior financials. First deliverable — usually a biological asset model review, excise reconciliation snapshot, or POS-to-GL alignment — lands the same week.
Weekly cadence + audit/regulator-ready
Standing weekly call, always-on Slack, weekly cash and inventory snapshot, monthly close by the 15th, quarterly impairment indicator review, CTLS or AGCO reporting alignment, audit prep, capital raise or restructuring prep when the moment comes. No help-desk queue, no offshore relay.
What Cannabis Operators Say After 90 Days.
My cannabis retail group operates four AGCO-licensed stores across Toronto with plans to add more within the 75-store cap. Our previous accountant knew the numbers but didn't understand cannabis retail — excise stamp inventory wasn't reconciled properly, Cova-to-QuickBooks integration was manual, and AGCO reporting was a monthly fire drill. Ledgerive rebuilt Cova integration properly, set up excise stamp reconciliation as controlled inventory, and aligned our books to AGCO reporting from day one. Cash and inventory clarity across all four stores improved materially and my next store approval package went in with real numbers.
I hold a Health Canada micro-cultivation and micro-processing licence outside Windsor and my previous accountant had no idea what to do with biological asset accounting or excise stamp reconciliation. ASPE inventory costing had never been properly set up, my cultivation cost absorption was inconsistent, and CTLS reporting didn't tie to my books. Ledgerive rebuilt the whole finance function from the ground up — proper ASPE cost-based inventory, cultivation cost absorption across drying and curing, excise stamp reconciliation as controlled inventory, and CTLS-aligned reporting. First Health Canada review since went smoothly.
I run an asset-light cannabis brand that licenses to Health Canada processors and sells through OCS and other provincial wholesalers. Brand economics are meaningfully different from grow economics — royalty accounting, licensor-licensee reconciliation, provincial wholesaler receivable management across multiple provinces, and product-level margin tracking. Ledgerive rebuilt the whole model, set up proper royalty accounting on both sides, and put multi-province receivable management in place. My next investor conversation had the depth of financial detail that sophisticated cannabis capital expects.
Our standard cultivator operation in the Leamington greenhouse belt reports under IFRS and the biological asset model had been a source of audit friction for years. Cost-to-sell assumptions weren't defensible, harvest-to-inventory transfer wasn't clean, and impairment testing had been informally done rather than properly documented. Ledgerive rebuilt the IAS 41 biological asset model with proper policy documentation, tightened harvest-to-inventory transfer discipline, and produced full IAS 36 impairment testing with sensitivity analysis. Our next audit cycle was materially cleaner and the auditor's specialists had far less to push back on.
Questions Cannabis Operators Ask.
Straight answers to the questions that come up on nearly every cannabis discovery call.
Do you handle biological asset accounting under IAS 41 for Licensed Producers?
Do you handle IFRS for public Licensed Producers and ASPE for private LPs?
Do you handle cannabis excise duty and provincial stamp reconciliation?
Is Section 280E an issue for Canadian cannabis operators?
Do you handle inventory valuation and cost of cultivation absorption?
Do you handle impairment testing after industry-wide writedowns?
Do you integrate with cannabis retail POS platforms (Cova, Greenline, Dutchie POS, Meadow)?
Do you handle Health Canada CTLS monthly reporting and AGCO retail compliance?
Do you handle cannabis-specific banking limitations?
Do you handle CCAA proceedings, restructuring and turnaround for cannabis operators?
Which Ontario and Canadian regions do you serve cannabis operators in?
How do you handle pricing?
Ready to get finance right for your cannabis operation?
30 minutes. NDA first. No pitch. Just a real conversation about your licence, your operations, your next 12 months, and whether we're the right team to deliver the finance work behind them.